IQV · NYSE · Life Sciences Tools & Services
Life Sciences Tools & Services company based in Durham, North Carolina.
Last close, Oct 1, 2026
$260.72
Adjusted for splits and dividends
Last 12 months
+27.9%
S&P 500 +14.3% over the same dates
Market value
$43.5B
Last close × shares outstanding
Bets against the stock: 4.12M shares sold short (2.5% of shares outstanding), +9.0% vs the previous count, 3.0 days of normal trading to buy them back. FINRA, as of Sep 15, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
9 sales
$29.9M sold. Insiders sell for many reasons.
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$16.3B
+5.9% vs the year before
Net income, fiscal 2025
$1.36B
As reported in the annual filing
Shares outstanding
167M
As of Apr 30, 2026
In fiscal 2025 the company spent $1.24B buying back its own shares. Cash actually paid, from its cash-flow statement.
Congress tradeSits on House Ways and Means, HealthHeld by the filer's joint per the disclosure. Disclosed 11 days after the transaction; reported as an official range, not an exact amount.
Congress tradeSits on House Ways and Means, HealthHeld by the filer's dependent child per the disclosure. Disclosed 17 days after the transaction; reported as an official range, not an exact amount.
Congress tradeSits on House Ways and Means, HealthHeld by the filer's dependent child per the disclosure. Disclosed 22 days after the transaction; reported as an official range, not an exact amount.
Stock since the trade -1.2% · S&P 500 -0.1% · to Oct 1
IQVIA's See Remarks sold $697K of IQVIA shares. Nobody planned it ahead of time.
A top manager at IQVIA told the SEC they plan to sell $697K of IQVIA shares around Sep 2, 2026. The shares did not come from their pay.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
66 certified in FY2026 Q3, vs 64 a year earlier. 66 positions in total, median offered wage $140K a year.
Labor condition applications for H-1B workers certified by the Department of Labor, counted by decision date (FY2026 Q3: Apr 1, 2026 to Jun 30, 2026, the latest quarter published). A certified application is a step before a visa petition, not a hire or a visa, and one application can cover several positions. Matched by employer ID number or name.
Anyone owning more than 5% must file within days. Structured filings exist since December 2024, so older stakes that were never amended may be missing.
Short sale volume: 38.1% of the volume reported to FINRA over the last 20 trading days was marked short, below its 1-year average of 51.0%. FINRA daily files, to Oct 2, 2026.
Fails to deliver: 4,960 shares (about $1.27M) were not delivered on time for settlement on Sep 10, 2026. SEC fails-to-deliver data.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock. Fails to deliver have many causes, including processing delays, and are often resolved within days.
Last 12 months, adjusted daily closes
Adjusted close went from $203.79 on Oct 1, 2025 to $260.72 on Oct 1, 2026 (+27.9%). Disclosed trades in the last 12 months: 0 insider purchases, 17 insider sales, 1 Congress purchase, 5 Congress sales.
Top officer leaving
“Bruehlman will retire, effective February 28, 2026, from his current role as Executive Vice President and Chief Financial Officer and transition to Senior Advisor to the CEO, ensuring continuity and a seamless transition.”
8-K on sec.govFrom the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.
